Adaptimmune Therapeutics PLC - SPONDS ADR (ADAP)

Q3 2021 13F Holders as of 9/30/2021

Type / Class
Equity / SPONDS ADR
Number of holders
90
Total Shares
112M
Shares change
-96.2K
Total reported value, excl. options
$577M
Value change
+$3.04M
Put/Call ratio
3.94
Number of buys
47
Number of sells
-27
Price
$5.17
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.